Open Access

The Wearable Cardioverter Defibrillator (WCD): Clinical Update and Future Directions for the Management of Patients with Ventricular Arrhythmias

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Prevention
Session type: Industry Q&A session
Sponsored by ZOLL
Date: 1 September 2020
Time: 18:30 - 19:30

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

Introduction.

Thumbnail

SCD Risk Stratification: Which Patient Benefits from the Wearable Cardioverter Defibrillator?

Speaker: Doctor M. Biffi (Bologna, IT)
Thumbnail

The Power of Per-Protocol Analyses: What Have We Learned from the VEST-Trial?

Speaker: Associate Professor S. Boveda (Toulouse, FR)
Thumbnail

Predictors of Sudden Cardiac Death: What Role Does the Heart Rate Play?

Speaker: Professor J. Sperzel (Bad Nauheim, DE)
Thumbnail

Heart Failure Patient Management: Improved Outcomes for WCD Patients?

Speaker: Professor D. Bondermann (Vienna, AT)
Thumbnail

Discussion and Summary.

Speaker: Professor C. Leclercq (Rennes, FR)
Thumbnail

5 speakers from this session

Doctor Mauro Biffi

S. Orsola-Malpighi Policlinic, Bologna (Italy)
26 presentations
0 follower

Associate Professor Serge Boveda

Clinic Pasteur of Toulouse, Toulouse (France)
15 presentations
0 follower

Professor Johannes Sperzel

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)
6 presentations
0 follower

Professor Diana Bondermann

Medical University of Vienna, Vienna (Austria)
5 presentations
0 follower

Professor Christophe Leclercq

University Hospital of Rennes - Hospital Pontchaillou, Rennes (France)
45 presentations
3 followers

This platform is supported by

logo Novo Nordisk